TTFields
TTFields is a medical device with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
50.0%
1 of 2 finished
50.0%
1 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
Preoperative Preradiotherapy TTFields
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
Clinical Trials (9)
Continued Access Program for Tumor Treating Fields (TTFields) Used With Chemotherapy (Gemcitabine and Nab-Paclitaxel) in Adults With Locally Advanced Pancreatic Cancer (PANOVA-3CA)
TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study
Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM
Preoperative Preradiotherapy TTFields
Effect of Timing of Tumor-Treating Fields Plus Short-Course Radiation
TIGER PRO-Active - Daily Activity, Sleep and Neurocognitive Functioning Study
Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma
TTFields In GErmany in Routine Clinical Care
A Prospective, Open-label, Single-arm Clinical Study
All 9 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 9